• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

This week in optometry: November 27-December 1


Catch up on what happened in optometry during the week of November 27-December 1.

Catch up with what Optometry Times®' shared this week:

Eye care providers express concern over Q3 revenue, staffing, and inflation

Sydney M Crago, Editor, Modern Retina

The Vision Council has released the results of their Provider InSights research study for Q3 2023. This study explores the sentiments of eye care providers in relation to the daily operations of their practices, the eye care industry, and the American economy and was conducted in October and November of 2023. Those surveyed include opticians, optometrists, ophthalmologists, eye care practice managers, eye care practice owners and other professionals.


Managing cases of dry eye: Expect the unexpected

Mile Brujic, OD, FAAO; Lynda Charters

Managing patients with dry eye disease may not be as clear-cut as it appears. Mile Brujic, OD, FAAO, shared his pearls with 2 challenging cases at a recent Ophthalmology Times and Optometry Times Case-Based Roundtable. He is a partner in the Premier Vision Group in Bowling Green, Ohio.


FDA issues complete response letter to Aldeyra Therapeutics for reproxalap NDA

David Hutton, Managing Editor, Ophthalmology Times

Aldeyra Therapeutics Inc announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) of reproxalap, an investigational drug candidate, for the treatment of dry eye disease.


Keep your contact lens practice on the cutting edge

Robert L. Rosenthal, OD

"This case [in this article] illustrates so many things about how to run a successful contact lens practice. First, I don’t ever want my patients to hear about new technology from someone else. I make it a priority that my staff and I stay abreast of the latest innovations so that we can offer better products before patients start complaining—and certainly before they are ready to drop out of lens wear."


The relationship between myopia and glaucoma

Benjamin P. Casella, OD, FAAO

One meta-analysis of 145 studies estimates that myopia, which affected 22% of individuals globally in 2000, will be present in 50% of the world’s population by 2050.1 This seems like quite a staggering statistic until you hone in on the developed countries in East Asia, where the prevalence of myopia in school-aged children is 80% to 90%.


Related Videos
Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
© 2024 MJH Life Sciences

All rights reserved.